Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
FTH-002 by Faeth Therapeutics for Rectal Cancer: Likelihood of Approval
FTH-002 is under clinical development by Faeth Therapeutics and currently in Phase I for Rectal Cancer. According to GlobalData, Phase...